SCHEMBL18624977

SCHEMBL18624977

O=S(=O)(O)c1ccc(/N=N/c2ccc(S(=O)(=O)O)cc2)cc1

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.83
▸ CYP2D6 P10635 1/20 0.83
▸ RPS6KA3 P51812 1/20 0.59
▸ LMNA P02545 1/20 0.56
▸ MEN1 O00255 2/20 0.55
▸ KMT2A Q03164 2/20 0.55
▸ PHLPP2 Q6ZVD8 1/20 0.54
▸ TSHR P16473 2/20 0.54
▸ ALDH1A1 P00352 1/20 0.54
▸ NT5E P21589 1/20 0.54
▸ CA12 O43570 4/20 0.54
▸ CA2 P00918 4/20 0.54
▸ CA9 Q16790 4/20 0.54
▸ CA7 P43166 1/20 0.54
▸ SMN1; SMN2 Q16637 1/20 0.52
▸ ATIC P31939 1/20 0.50
▸ GLO1 Q04760 1/20 0.49
▸ SUMO2 P61956 1/20 0.49
▸ SUMO1 P63165 1/20 0.49
▸ SENP7 Q9BQF6 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28560987 1.00 POLB (0.83) POLBCYP2D6RPS6KA3LMNAMEN1
SCHEMBL2171353 0.91 LMNA (0.74) POLBCYP2D6RPS6KA3LMNAMEN1
SCHEMBL4808253 0.91 LMNA (0.74) POLBCYP2D6RPS6KA3LMNAMEN1
SCHEMBL408153 0.91 POLB (1.00) POLBCYP2D6RPS6KA3LMNAMEN1
SCHEMBL6563719 0.91 POLB (1.00) POLBCYP2D6RPS6KA3LMNAMEN1
SCHEMBL9612273 0.89 POLB (0.68) POLBCYP2D6RPS6KA3LMNAMEN1
SCHEMBL4489023 0.89 LMNA (0.71) POLBCYP2D6RPS6KA3LMNAMEN1
SCHEMBL5752505 0.89 TSHR (0.75) POLBCYP2D6RPS6KA3LMNAMEN1
SCHEMBL13154694 0.89 POLB (0.68) POLBCYP2D6RPS6KA3LMNAMEN1
SCHEMBL28788411 0.89 POLB (0.96) POLBCYP2D6RPS6KA3LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10995365-B2 Compounds and systems for improving signal detection PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 2021-05-04 — — US disclosed
EP-3350350-B1 COMPOUNDS AND SYSTEMS FOR IMPROVING SIGNAL DETECTION PACIFIC BIOSCIENCES CALIFORNIA INC (US) 2021-04-14 — — EP disclosed
US-10435741-B2 Compounds and systems for improving signal detection PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) 2019-10-08 — — US disclosed
US-20190106742-A1 COMPOUNDS AND SYSTEMS FOR IMPROVING SIGNAL DETECTION PACIFIC BIOSCIENCES CALIFORNIA INC (US) 2019-04-11 — — US disclosed
US-20170145494-A1 COMPOUNDS AND SYSTEMS FOR IMPROVING SIGNAL DETECTION PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 2017-05-25 — — US disclosed
US-20170072070-A1 METAL-ORGANIC FRAMEWORK STIMULUS RESPONSIVE POLYMER COMPOSITE CAPABLE OF CONTROLLING RELEASE OF GUEST NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) 2017-03-16 — — US disclosed
US-20170072070-A1 METAL-ORGANIC FRAMEWORK STIMULUS RESPONSIVE POLYMER COMPOSITE CAPABLE OF CONTROLLING RELEASE OF GUEST NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) 2017-03-16 — — US disclosed
EP-3141263-A1 METAL-ORGANIC FRAMEWORK/STIMULUS-RESPONSIVE POLYMER COMPOSITE CAPABLE OF CONTROLLING RELEASE OF GUEST National University Corporation Hokkaido University (JP) 2017-03-15 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170072070-A1 METAL-ORGANIC FRAMEWORK STIMULUS RESPONSIVE POLYMER COMPOSITE CAPABLE OF CONTROLLING RELEASE OF GUEST ORAI1, SARAF, TRPM8 POLB 4374/4885CYP2D6 4834/4885RPS6KA3 3896/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback